Since its inception, AesMed Co., Ltd. has stood at the forefront of innovation in the field of alopecia treatment, mesotherapy, and aesthetic medicine. With a strong foundation in clinical science and a deep commitment to professional collaboration, AesMed has evolved into a trusted leader in hair restoration solutions not only in Korea, but across key international markets including Japan, China, Türkiye, and Malaysia
A Trailblazer in Alopecia Treatment
AesMed’s journey began in the early 2000s, when it spearheaded the Korean alopecia and aesthetic market development project. Since then, the company has consistently introduced game-changing innovations:
• 2005–2008:
Development of Korea’s first mesotherapy products for hair loss, including SGF-57, based on growth factor cytokines.
• 2009:
Initiated Auto-MTS therapy and hosted Korea’s first stem cell seminar on alopecia.
• 2010–2011:
Pioneered net-free medical wigs and supported the World Congress of Dermatology in Seoul.
• 2012–2014:
Published clinical trial results in SCI journals and presented findings at global congresses in Edinburgh and Jeju, reinforcing its scientific credibility.
These milestones laid the groundwork for the development of AGF39™, a professional mesotherapy solution utilizing a unique blend of 7 cytokines to address DHT-induced hair loss and normalize the hair cycle.
AGF39™: The Standard in Cytokine-Based Mesotherapy
Officially launched in 2016, AGF39™ quickly became the most widely used mesotherapy solution for hair loss in Korea and Japan. With over 5 million procedures performed globally, AGF39™ is now considered the “MESOTHERAPY STANDARD” for hair follicle regeneration and activation. The product continues to evolve with international certifications including CPNP (EU), SCPN (UK), and IHCC HALAL, reflecting AesMed’s commitment to global safety and compliance standards.
Global Participation & Recognition
AesMed’s commitment to excellence is evident through its participation in renowned events:
• KIMES (Korea International Medical & Hospital Equipment Show): 2019, 2022, 2023, 2024, 2025
• Cosmoprof Asia: 2023, 2024
• Hair Care Day Campaign 2024: Advocating hair health awareness across Asia
• International Distributorships: Strategic partnerships in Japan, China, Türkiye, and Malaysia
KOL Engagement: Partnering with Medical Experts
AesMed’s strong reputation is built on collaboration with Key Opinion Leaders (KOLs) and leading professional societies. Its active involvement includes:
• World Congress for Hair Research (2013, 2014)
• Asian Association of Hair Restoration Surgeons (AAHRS)
• Korean Hair Research Society
• Korean Society of Hair Restoration Treatment & Surgery
• Association of Korean Dermatologists
• Korea Dermatological Association
• Korean Association for Laser, Dermatology, and Trichology
• Academy of Korea Mesotherapy
• Asian Academy of Anti-aging & Aesthetic Medicine
Through these partnerships, AesMed continually refines its protocols based on feedback from dermatologists, trichologists, and aesthetic clinicians.
Conclusion
With a rich history of innovation and trusted collaboration with global experts, AesMed is not just a product provider—it is a visionary force shaping the future of hair restoration.
As the originator of cytokine-based mesotherapy, AesMed remains committed to delivering safe, effective, and science-backed solutions that empower professionals and restore confidence to patients worldwide.
Visit www.aesmed.co.kr to learn more about AGF39™ and join the next chapter in hair regeneration.
